전망 요약
Positive expansion into the healthcare sector through a major joint investment for AI-driven drug discovery.
주요 포인트
- Partnering with Eli Lilly for a joint AI lab
- Investment ranges between $500 million to $1 billion over five years
- Focus on leveraging AI for drug development
